Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Boehringer Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Boehringer Milestone

Evotec AG has received a $3.1 million milestone payment through its research alliance with Boehringer Ingelheim.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has received a $3.1 million milestone payment through its research alliance with Boehringer Ingelheim. The milestone was achieved for the selection of a candidate compound for pre-development studies in an oncology program.

Dr. Werner Lanthaler, chief executive officer of Evotec, commented, “We are particularly pleased about achieving this milestone in the oncology program, as the alliance was only expanded to this therapeutic area in late 2009. We are very proud of the high value we continue to bring to Boehringer Ingelheim’s research efforts and the ongoing fruitful relationship between the research teams from both companies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters